Vous n'êtes pas connecté
EDINBURGH, Scotland & BOSTON — RoslinCT, a leading cell and gene therapy Contract Development and Manufacturing Organisation (CDMO), is pleased to announce the appointment of Professor Sir Peter Mathieson MB BS (Hons), PhD, FRCP, FRCPE, FMedSci, FRSE, FRSA and Alexander Vos as new Non-Executive Directors. Professor Sir Peter Mathieson brings an exceptional wealth of experience […]
New executive brings extensive financial and clean energy expertise to his new role at CF Industries.
Image: FocusStocker/shutterstock.comBlack Cat Syndicate and St Barbara have farewelled non-executive directors from their ranks. Black Cat Syndicate...
Image: jovannig/stock.adobe.comThe Rail Tram and Bus Union (RTBU) National Executive has appointed Alex Claassens as the union’s new National...
Avantor's (AVTR) solutions are intended to provide gene therapy manufacturers with sustainable and efficient alternatives to traditional methods, thus...
Avantor's (AVTR) solutions are intended to provide gene therapy manufacturers with sustainable and efficient alternatives to traditional methods, thus...
June 19th is World Sickle Cell Day, and to raise awareness about the condition, Wunmi Bakare and Dima Hendricks are launching a podcast. Both women...
MONDAY, June 24, 2024 -- The U.S. Food and Drug Administration has expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene...